Adrenergic transmission properties and implication
Adrenergic transmission properties and implication
批准号:
10637114
负责人:
Mark Beenhakker
金额:
$40.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2028-02-29
关键词:
Adrenergic AgentsAdrenergic ReceptorAlgorithmic AnalysisAlzheimer&aposs DiseaseArousalAttentionAttentional deficitBehaviorBiological ProcessBrainCardiovascular DiseasesCell NucleusCentral Nervous SystemClinicalCognitionComplexCouplingDataDepressive disorderDiffusionEngineeringEpinephrineEventFamilyFutureG-Protein-Coupled ReceptorsGoldGreen Fluorescent ProteinsHealthHeartHumanImage AnalysisImmuneIndividualInvestigationLinkMental disordersMicroscopicMonitorMusNeuronsNeurotransmittersNorepinephrineOrganOutputPancreasParkinson DiseasePathologicPerformancePeripheralPeripheral Nervous SystemPhysiologicalPhysiological ProcessesPlayPontine structurePreparationProbabilityPropertyReceptor ActivationRegulationResearchResolutionRoleSchemeSchizophreniaSensorySignal TransductionSiteSleepSleep DisordersSpleenSynapsesTestingTissuesVisualizationWood materialautism spectrum disordercognitive functionexperimental studyimprovedlocus ceruleus structuremonoaminenervous system disorderneurotransmissionnovelsensortooltransmission processtumorigenesisultra high resolution
中文摘要
项目总结
去甲肾上腺素(NE)和肾上腺素(Epi)与复杂的认知功能有关,
例如感觉处理、睡眠-觉醒/觉醒状态转换和注意力
在各种组织和器官中的生物过程,包括心脏、胰腺和脾。
肾上腺素能传递的失调与许多神经系统疾病有关,包括
阿尔茨海默氏症、抑郁障碍和精神分裂症,以及许多其他健康问题,
包括心血管疾病、免疫缺陷和肿瘤发生。
尽管NE/Epi可能参与多种生理和病理情况,
肾上腺素能传递的精确调节和确切的功能作用仍然不清楚,因为
主要是由于可用于监测NE/EPI的工具的局限性。我们最近发展了一个家庭
基于强度的G蛋白偶联受体(GPCR)激活基于遗传编码的NE
环状置换绿色荧光蛋白(CpGFP)与人
肾上腺素能受体。当这些GRABNE传感器允许首次看到肾上腺素能
传输,传感器在确定肾上腺素能突触特性方面是次优的。
变速箱。为了促进NE/EPI的研究,我们最近设计了高性能的GRABNE
允许高灵敏度和高分辨率可视化肾上腺素能传递事件的传感器
在单一的释放地点。新的传感器和初步数据增强了我们测试
高性能GRABNE传感器可能解决肾上腺素能传递的假说
可以推断肾上腺素能功能作用的性质。此应用程序遵循两个特定的
目的:目的1是确定高性能的GRABNE传感器是否可以分解肾上腺素能
传递特性,目标2是测试肾上腺素能传递是否在
要求精确度和注意力的行为。我们预计拟议中的实验将
描述一种新形式的神经元传递的第一组基本突触属性和
为肾上腺素能传递定义一个新的、独特的功能角色。
英文摘要
PROJECT SUMMARY
Norepinephrine (NE) and epinephrine (Epi) have been implicated in complex cognitive functions,
such as sensory processing, sleep-wake/arousal state transition and attention, in the brain, and other
biological processes in various tissues and organs, including the heart, pancreas and spleen.
Dysregulation of adrenergic transmission is linked to a number of neurological diseases, including
Alzheimer’s disease, depressive disorders and schizophrenia, as well as many other health problems,
including cardiovascular diseases, immune-deficiency and tumorigenesis.
Despite the potential involvement of NE/Epi in myriad physiological and pathological conditions,
the precise regulation and exact functional role of adrenergic transmission remain poorly defined, due
primarily to limitations of available tools for monitoring NE/Epi. We have recently developed a family
of intensity-based G-protein-coupled receptor (GPCR) activation-based genetically encoded NE
(GRABNE) sensors by coupling a circular permutated green fluorescent protein (cpGFP) with a human
adrenergic receptor. While these GRABNE sensors allowed the first visualization of adrenergic
transmission, the sensors were suboptimal in determining synaptic properties of adrenergic
transmission. To facilitate NE/Epi research, we recently engineered high-performance GRABNE
sensors that allowed high-sensitivity and high-resolution visualization of adrenergic transmission events
at single release sites. The new sensors and preliminary data build up our confidence to test the
hypothesis that high-performance GRABNE sensors may resolve the adrenergic transmission
properties that could deduce the adrenergic functional role. This application follows two specific
aims: Aim 1 is to determine whether high-performance GRABNE sensors may resolve adrenergic
transmission properties, and Aim 2 is to test whether adrenergic transmission plays an essential role in
the precision- and attention-demanding behaviors. We expect the proposed experiments to
characterize the first set of fundamental synaptic properties of a new form of neuronal transmission and
define a novel, unique functional role for adrenergic transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Architectonic analysis of complex cortical circuits in healthy and diseased brain
-
批准号:10749697
-
项目类别:
-
资助金额:$204.16万
-
财政年份:2023
-
负责人:Mark Beenhakker
-
依托单位:
Respiration and Generalized Epilepsies
-
批准号:10596189
-
项目类别:
-
资助金额:$54.04万
-
财政年份:2022
-
负责人:Mark Beenhakker
-
依托单位:
Energy and Neural Circuit Excitability
-
批准号:10416150
-
项目类别:
-
资助金额:$41.91万
-
财政年份:2016
-
负责人:Mark Beenhakker
-
依托单位:
Enhanced excitation and epilepsy with chloride channel dysfunction
-
批准号:8385715
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Mark Beenhakker
-
依托单位:
Enhanced excitation and epilepsy with chloride channel dysfunction
-
批准号:8396375
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2011
-
负责人:Mark Beenhakker
-
依托单位:
Enhanced excitation and epilepsy with chloride channel dysfunction
-
批准号:8586278
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2011
-
负责人:Mark Beenhakker
-
依托单位:
Enhanced excitation and epilepsy with chloride channel dysfunction
-
批准号:7642720
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2009
-
负责人:Mark Beenhakker
-
依托单位:
Motor Pattern Selection From a Multifunctional Network
-
批准号:6606962
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2002
-
负责人:Mark Beenhakker
-
依托单位:
Motor Pattern Selection From a Multifunctional Network
-
批准号:6540499
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2002
-
负责人:Mark Beenhakker
-
依托单位:
Motor Pattern Selection From a Multifunctional Network
-
批准号:6339651
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2001
-
负责人:Mark Beenhakker
-
依托单位:
海外基金